-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Aurinia Pharmaceuticals Inc. quarterly/annual Interest Expense history and growth rate from 2021 to 2023.
- Aurinia Pharmaceuticals Inc. Interest Expense for the quarter ending June 30, 2024 was $1.2M, a 1743% increase year-over-year.
- Aurinia Pharmaceuticals Inc. Interest Expense for the twelve months ending June 30, 2024 was $5.19M.
- Aurinia Pharmaceuticals Inc. annual Interest Expense for 2023 was $2.78M.
- Aurinia Pharmaceuticals Inc. annual Interest Expense for 2022 was $0.000.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)